MPM Bioventures 2018, L.P., 10% Owner at iTeos Therapeutics, Inc. (ITOS), sold 115,532 shares at $28.61 ($2.4M) on 2021-09-08, disclosed to the SEC on 2021-09-08.
Scheduled sale ($2.4M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 31,340 | $0 | 0.0% |
| 2 | $29.18 | 30,474 | $889K | 36.4% |
| 3 | $29.18 | 30,474 | $889K | 36.4% |
| 4 | $28.61 | 11,152 | $319K | 13.1% |
| 5 | $28.61 | 11,152 | $319K | 13.1% |
| 6 | $29.10 | 940 |
| $27K |
| 1.1% |
| Total | $21.15 avg | 115,532 | $2.4M | 100% |
| Filing → |
| TRDA | SELL | 2026-08-31 | $616K | — | Filing → |
| TRDA | SELL | 2026-08-26 | $462K | — | Filing → |
| AKTS | BUY | 2026-01-14 | $20.0M | — | Filing → |